Obesity paradox in cancer: New insights provided by body composition

American Journal of Clinical Nutrition

Volumn 99, Issue 5, 2014, Pages 999-1005

  Gonzalez, Maria Cristina ^a,c,d   Pastore, Carla A ^b,d   Orlandi, Silvana P ^b,d   Heymsfield, Steven B ^c  

^a CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d Study Group on Body Composition and Nutrition COCONUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSITY; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SARCOPENIA;

EID: 84899000249     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.071399     Document Type: Article

References (38)

1. World Health Organization. Are the number of cancer cases increasing or decreasing in the world? Available from: http://www.who.int/features/qa/15/en/ index.html (cited 8 December 2012).
2. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489-95.
3. García-Luna PP, Parejo Campos J, Pereira Cunill JL. Causes and impact of hyponutrition and cachexia in the oncologic patient Nutr Hosp 2006;21(suppl 3):10-6 (in Spanish).
4. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010;29: 154-9.
5. Amundson DE, Djurkovic S, Matwiyoff GN. The obesity paradox. Crit Care Clin 2010;26:583-96.
6. Di Luzio R, Moscatiello S, Marchesini G. Role of nutrition in gastrointestinal oncological patients. Eur Rev Med Pharmacol Sci 2010; 14:277-84.
7. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-54.
8. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, Morley JE. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007;10:433-42.
9. Myers J, Lata K, Chowdhury S, McAuley P, Jain N, Froelicher V. The obesity paradox and weight loss. Am J Med 2011;124:924-30.
10. Shirley S, Davis LL, Carlson BW. The relationship between body mass index/body composition and survival in patients with heart failure. J Am Acad Nurse Pract 2008;20:326-32.
11. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996;12(suppl):S15-9.
12. Kyle UG, Pirlich M, Lochs H, Schuetz T, Pichard C. Increased length of hospital stay in underweight and overweight patients at hospital admission: a controlled population study. Clin Nutr 2005; 24:133-42.
13. Paiva SI, Borges LR, Halpern-Silveira D, Assuncao MC, Barros AJ, Gonzalez MC. Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 2010;19:187-92.
14. Halpern-Silveira D, Susin LR, Borges LR, Paiva SI, Assuncao MC, Gonzalez MC. Body weight and fat-free mass changes in a cohort of patients receiving chemotherapy. Support Care Cancer 2010;18: 617-25.
15. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39:578-84.
16. Valentijn TM, Galal W, Tjeertes EK, Hoeks SE, Verhagen HJ, Stolker RJ. The obesity paradox in the surgical population. Surgeon 2013;11: 169-76.
17. Pickkers P, de Keizer N, Dusseljee J, Weerheijm D, van der Hoeven JG, Peek N. Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Crit Care Med 2013;41:1878-83.
18. Huschak G, Busch T, Kaisers UX. Obesity in anesthesia and intensive care. Best Pract Res Clin Endocrinol Metab 2013;27:247-60.
19. Greenberg JA. The obesity paradox in the US population. Am J Clin Nutr 2013;97:1195-200.
20. Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013;7:85-94.
21. Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, Feinstein D, Parrillo JE, Wood KE, Keenan SP, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care 2013; 17:R72.
22. Srikanthan P, Horwich TB. The obesity paradox: time for a new look at an old paradigm. Rev Esp Cardiol 2012;65:403-4.
23. Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012;3:1-4.
24. World Health Organization. The problem of overweight and obesity. Available from: http://whqlibdoc.who.int/trs/WHO-TRS-894-(part1).pdf (cited 8 December 2012).
25. Pischon T. Commentary: use of the body mass index to assess the risk of health outcomes: time to say goodbye? Int J Epidemiol 2010;39: 528-9.
26. Casas-Vara A, Santolaria F, Fernandez-Bereciartua A, Gonzalez-Reimers E, Garcia-Ochoa A, Martinez-Riera A. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 2012;28:616-22.
27. Jensen GL, Mirtallo J, Compher C, Dhaliwal R, Forbes A, Grijalba RF, Hardy G, Kondrup J, Labadarios D, Nyulasi I, et al. Adult starvation and disease-related malnutrition: a proposal for etiologybased diagnosis in the clinical practice setting from the International Consensus Guideline Committee. Clin Nutr 2010;29: 151-3.
28. Massicotte MH, Borget I, Broutin S, Baracos VE, Leboulleux S, Baudin E, Paci A, Deroussent A, Schlumberger M, Antoun S. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. J Clin Endocrinol Metab 2013;98:2401-8.
29. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008;9:629-35.
30. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012;10:166-73, 173 e1.
31. Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR, Sawyer MB. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013;47:861-70.
32. Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP, Greenland S. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 2012; 175:793-803.
33. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23.
34. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012;31: 583-601.
35. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy x-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2013;61:974-80.
36. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008;11:693-700.
37. Visser M, van Venrooij LM, Vulperhorst L, de Vos R,WisselinkW, van Leeuwen PA, de Mol BA. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis 2013;23:511-8.
38. Soeters PB, Sobotka L. The pathophysiology underlying the obesity paradox. Nutrition 2012;28:613-5.